Transcatheter aortic valve implantation (TAVI) has become a high-volume procedure with increasing demands on hospital resources. Local anaesthesia with sedation supervised by an anaesthesiology team is the current standard of care. We aimed to describe our experience with a simplified, nurse-led sedation (NLS) protocol. This study enrolled 128 consecutive patients who underwent transfemoral TAVI with self-expandable Evolut R prosthesis between November 2019 and April 2021. Operators selected 50% of patients for NLS based on the clinical expectation of lower risk of procedural difficulties. Nurse-led sedation protocol demanded only mild to moderate levels of sedation. The clinical outcomes were determined from the local TAVI registry and the national mortality database. Baseline patient characteristics were similar in the NLS (n = 64) and anaesthesiologist-led sedation (ALS) (n = 64) groups except higher prevalence of diabetes mellitus (48.4% vs. 31.3%, P = 0.035) and peripheral vascular disease (20.3% vs. 7.8%, P = 0.036) in the ALS group. There was a trend for the larger prostheses used in the ALS group (P = 0.058). The procedural results did not differ, and coronary care team backup was rarely needed in the NLS group (6% of patients). The in-hospital outcomes were identical from both clinical and echocardiography perspectives, and 30-day mortality was low in both groups (1.5%). For the NLS group, preparation in the catheterization laboratory was quicker by 6.4 min (P = 0.01), and intensive care unit stay was shorter (2.03 vs. 3.48 days, P = 0.001). In conclusion, the NLS for the selected transfemoral TAVI population seems safe.

Department of Anaesthesia and Intensive Care Medicine 3rd Faculty of Medicine University Hospital Královské Vinohrady Charles University Šrobárova 50 Prague 100 34 Czech Republic

Department of Cardiology 3rd Faculty of Medicine University Hospital Královské Vinohrady Charles University Šrobárova 50 Prague 100 34 Czech Republic

Medtronic Czechia Prosecká 66 Prague 190 00 Czech Republic

Zobrazit více v PubMed

Fröhlich GM, Lansky AJ, Webb J, Roffi M, Toggweiler S, Reinthaler M, Wang D, Hutchinson N, Wendler O, Hildick-Smith D, Meier P.. Local versus general anesthesia for transcatheter aortic valve implantation (TAVR)—systematic review and meta-analysis. BMC Med 2014;12:41. PubMed PMC

Thiele H, Kurz T, Feistritzer H-J, Stachel G, Hartung P, Lurz P, Eitel I, Marquetand C, Nef H, Doerr O, Vigelius-Rauch U, Lauten A, Landmesser U, Treskatsch S, Abdel-Wahab M, Sandri M, Holzhey D, Borger M, Ender J, Ince H, Öner A, Meyer-Saraei R, Hambrecht R, Fach A, Augenstein T, Frey N, König IR, Vonthein R, Rückert Y, Funkat A-K, Desch S, Berggreen AE, Heringlake M, de Waha-Thiele S; On behalf of the SOLVE-TAVI Investigators. General versus local anesthesia with conscious sedation in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial. Circulation 2020;142:1437–1447. PubMed

Vora AN, Rao SV.. Percutaneous or surgical access for transfemoral transcatheter aortic valve implantation. J Thorac Dis 2018;10:S3595–S3598. PubMed PMC

Martin GP, Sperrin M, Bagur R, de Belder MA, Buchan I, Gunning M, et al.Pre-implantation balloon aortic valvuloplasty and clinical outcomes following transcatheter aortic valve implantation: a propensity score analysis of the UK registry. J Am Heart Assoc 2017;6:e004695. PubMed PMC

McInerney A, Vera-Urquiza R, Tirado-Conte G, Marroquin L, Jimenez-Quevedo P, Nuñez-Gil I, Pozo E, Gonzalo N, de Agustín JA, Escaned J, Fernández-Ortiz A, Macaya C, Nombela-Franco L.. Pre-dilation and post-dilation in transcatheter aortic valve replacement: indications, benefits and risks. Interv Cardiol 2021;16:e28. PubMed PMC

Faurie B, Souteyrand G, Staat P, Godin M, Caussin C, Van Belle E, Mangin L, Meyer P, Dumonteil N, Abdellaoui M, Monségu J, Durand-Zaleski I, Lefèvre T; EASY TAVI Investigators. Left ventricular rapid pacing via the valve delivery guidewire in transcatheter aortic valve replacement. JACC Cardiovasc Interv 2019;12:2449–2459. PubMed

Radhakrishnan SL, Ho KK.. Transradial vs transfemoral secondary access outcomes in transcatheter aortic valve implantation: a systematic review and meta-analysis. World J Cardiol 2020;12:571–583. PubMed PMC

Konigstein M, Ben-Shoshan J, Zahler D, Flint N, Margolis G, Granot Y, Aviram G, Halkin A, Keren G, Banai S, Finkelstein A.. Outcome of patients undergoing TAVR with and without the attendance of an anesthesiologist. Int J Cardiol 2017;241:124–127. PubMed

Vendrik J, de Boer J, Zwiers W, van Gilst SA, Holierook M, Chekanova EV, Henriques JS, Baan J.. Ongoing transcatheter aortic valve implantation (TAVI) practice amidst a global COVID-19 crisis: nurse-led analgesia for transfemoral TAVI. Neth Heart J 2020;28:384–386. PubMed PMC

Sathananthan J, Webb JG, Lauck SB, Cairns J, Humphries KH, Nazif T, Thourani VH, Cohen DJ, Leon MB, Wood DA; 3M TAVR Study Investigators. Impact of local anesthesia only versus procedural sedation using the Vancouver clinical pathway for TAVR: insights from the 3M TAVR study. JACC Cardiovasc Interv 2019;12:1000–1001. PubMed

Keegan P, Lisko JC, Kamioka N, Maidman S, Binongo JN, Wei J, Vadlamudi R, Edwards JK, Vatsa N, Maini A, Reginauld S, Gleason P, Stewart J, Devireddy C, Block PC, Greenbaum A, Guyton RA, Babaliaros VC.. Nurse led sedation: the clinical and echocardiographic outcomes of the 5-year Emory experience. Struct Heart 2020;4:302–309.

Ramsay MA, Savege TM, Simpson BR, Goodwin R.. Controlled sedation with alphaxalone-alphadolone. Br Med J 1974;2:656–659. PubMed PMC

Tang GHL, Zaid S, Michev I, Ahmad H, Kaple R, Undemir C, Cohen M, Lansman SL.. "Cusp-overlap" view simplifies fluoroscopy-guided implantation of self-expanding valve in transcatheter aortic valve replacement. JACC Cardiovasc Interv 2018;11:1663–1665. PubMed

Généreux P, Piazza N, Alu MC, Nazif T, Hahn RT, Pibarot P, Bax JJ, Leipsic JA, Blanke P, Blackstone EH, Finn MT, Kapadia S, Linke A, Mack MJ, Makkar R, Mehran R, Popma JJ, Reardon M, Rodes-Cabau J, Van Mieghem NM, Webb JG, Cohen DJ, Leon MB; VARC-3 WRITING COMMITTEE. Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. Eur Heart J 2021;42:1825–1857. PubMed

Motloch LJ, Rottlaender D, Reda S, Larbig R, Bruns M, Müller-Ehmsen J, Strauch J, Madershahian N, Erdmann E, Wahlers T, Hoppe UC.. Local versus general anesthesia for transfemoral aortic valve implantation. Clin Res Cardiol 2012;101:45–53. PubMed

Greif M, Lange P, Näbauer M, Schwarz F, Becker C, Schmitz C, Pohl T, D'Anastasi M, Boekstegers P, Massberg S, Kupatt C.. Transcutaneous aortic valve replacement with the Edwards SAPIEN XT and Medtronic CoreValve prosthesis under fluoroscopic guidance and local anaesthesia only. Heart 2014;100:691–695. PubMed

Durand E, Borz B, Godin M, Tron C, Litzler P-Y, Bessou J-P, Bejar K, Fraccaro C, Sanchez-Giron C, Dacher J-N, Bauer F, Cribier A, Eltchaninoff H.. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes. JACC Cardiovasc Interv 2012;5:461–467. PubMed

Tuna Katircibasi M, Gunes H, Cagri Aykan A, Aksu E, Ozgul S.. Comparison of ultrasound guidance and conventional method for common femoral artery cannulation: a prospective study of 939 patients. Acta Cardiol Sin 2018;34:394–398. PubMed PMC